Does Power & Vaccine Politics Lead to State Usurpation of Ivermectin License?

As it turns out, Indonesia during the pandemic has been home to one of the largest, most dynamic, yet borderline illegal ivermectin markets worldwide, targeting the SARS-CoV-2 pandemic. That’s because an enterprising, well-known entrepreneur in his 70s capitalized on growing demand in the world’s fourth-most populated nation with the onset of the pandemic over a year ago.&nbsp;In what seems like an inadvertent, almost haphazard move by the central government to exploit positive sales growth of the drug actually appears to be far more about usurping control from the marketplace—and the people—restricting access to the drug and importantly, appeasing global influencers, such as the World Health Organization (WHO) and various governments that may be positioning vaccines, for example. How else can such a rollercoaster of a story unfold, one where what appears to be a healthy supply of ivermectin to treat COVID-19 people coupled with a surprisingly stable management of the COVID-19 pandemic to a case where the supply became absolutely constrained directly in parallel with the most massive spike of the pandemic starting in June of 2021.&nbsp;While it would be foolish to suggest this was the result of a conspiracy, it’s certainly understandable how one could come to that conclusion.


